Celularity (CELU) Fundamental Analysis: Revenue, Earnings & Valuation

8.50 / 10

Outperform

Fundamental analysis rates Celularity as Outperform with an 8.5/10 score. Strong points include PB‑ROE, Cash‑MV, Asset‑MV and Revenue‑MV, while Fixed‑asset turnover, Gross‑margin and YoY revenue decline are weaknesses. Overall, fundamentals are robust but show some operational concerns.

Analysis Checks(8/10)

Revenue-MV

Value-0.75

Score3/3

Weight38.91%

1M Return9.01%

Total operating revenue (YoY growth rate %)

Value-37.80

Score2/3

Weight-2.98%

1M Return-1.06%

Inventory turnover ratio

Value3.19

Score2/3

Weight-3.47%

1M Return-1.21%

Gross profit margin (%)

Value43.42

Score0/3

Weight-18.04%

1M Return-7.24%

PB-ROE

Value-0.63

Score2/3

Weight23.33%

1M Return6.97%

Income tax / Total profit (%)

Value0.00

Score2/3

Weight3.30%

1M Return1.04%

Fixed assets turnover ratio

Value0.38

Score1/3

Weight-3.44%

1M Return-1.24%

Cost of sales ratio (%)

Value56.58

Score2/3

Weight-11.85%

1M Return-4.42%

Asset-MV

Value-0.49

Score3/3

Weight52.33%

1M Return11.84%

Cash-MV

Value-0.09

Score2/3

Weight21.90%

1M Return5.94%

Is CELU undervalued or overvalued?

CELU scores 8.50/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -198.75% net margin, -0.51 P/E ratio, -1.88 P/B ratio, and -175.21% earnings growth, these metrics solidify its Outperform investment rating.